Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016)

Cytosorbents (CTSO) posted Change in Acquisitions & Divestments of $249000.0 for Q3 2016, down 87.18% on a QoQ basis from $1.9 million in Q2 2016, and down 83.33% year-over-year from $1.5 million in Q4 2015.

Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016) Analysis & Trends

Cytosorbents' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $249000.0 for Q3 2016.

  • Quarterly Change in Acquisitions & Divestments fell 83.33% year-over-year to $249000.0 in Q3 2016, while the trailing twelve-month figure through Dec 2017 was $2.2 million (changed 0.0% YoY) and the FY2016 annual result came in at $2.2 million, down 59.64% from the prior year.
  • Change in Acquisitions & Divestments was $249000.0 for Q3 2016 at Cytosorbents, down from $1.9 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $1.9 million in Q2 2016 and bottomed at $249000.0 in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Cytosorbents 22.58 Mn 17.78 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Sep 30, 2016 249,000.00
Sep 30, 2016 249,000.00
Jun 30, 2016 1.94 Mn
Jun 30, 2016 1.94 Mn
Dec 31, 2015 1.49 Mn
Dec 31, 2015 1.49 Mn
Sep 30, 2015 1.49 Mn
Sep 30, 2015 1.49 Mn
Jun 30, 2015 1.20 Mn
Jun 30, 2015 1.20 Mn
Mar 31, 2015 1.25 Mn
Mar 31, 2015 1.25 Mn